Neutrophils Mediate Pulmonary Artery Thrombosis In Situ

Pulmonary embolism is a life-threatening condition, which can result in respiratory insufficiency and death. Blood clots occluding branches of the pulmonary artery (PA) are traditionally considered to originate from thrombi in deep veins (usually in legs). However, growing evidence suggests that occlusion of the vessels in the lungs can develop without preceding deep vein thrombosis (DVT). In this work, we used an inferior vena cava (IVC) complete ligation model of DVT in Wistar rats to explore the possibility and mechanisms of PA thrombosis under the conditions where all routes of thrombotic mass migration from peripheral veins are blocked. We demonstrate that rats both with normal and reduced neutrophil counts developed thrombi in the IVC, although, neutropenia caused a substantial decrease in thrombus size and a shift from fresh fibrin toward mature fibrin and connective tissue inside the thrombus. Massive fibrin deposition was found in the PA branches in the majority of DVT rats with normal neutrophil counts, but in none of the neutropenic animals. Neutrophil ablation also abolished macroscopic signs of lung damage. Altogether, the results demonstrate that thrombi in the lung vasculature can form in situ by mechanisms that require local neutrophil recruitment taking place in the DVT setting.

[1]  D. Moreira-Gonçalves,et al.  Nets, pulmonary arterial hypertension, and thrombo-inflammation , 2022, Journal of Molecular Medicine.

[2]  Kevin D. Moss,et al.  Fibrin is a critical regulator of neutrophil effector function at the oral mucosal barrier , 2021, Science.

[3]  Gustaaf G. de Ridder,et al.  Novel venous thromboembolism mouse model to evaluate the role of complete and partial factor XIII deficiency in pulmonary embolism risk , 2021, Journal of Thrombosis and Haemostasis.

[4]  Yunshan Cao,et al.  In situ Pulmonary Artery Thrombosis: A Previously Overlooked Disease , 2021, Frontiers in Pharmacology.

[5]  A. Brill,et al.  University of Birmingham Neutrophil extracellular traps and inflammasomes cooperatively promote venous thrombosis in mice , 2021 .

[6]  K. Preissner,et al.  Neutrophil extracellular traps promote fibrous vascular occlusions in chronic thrombosis. , 2020, Blood.

[7]  M. Rudelius,et al.  Immunothrombotic Dysregulation in COVID-19 Pneumonia Is Associated With Respiratory Failure and Coagulopathy , 2020, Circulation.

[8]  A. Brill,et al.  Pulmonary Artery Thrombosis: A Diagnosis That Strives for Its Independence , 2020, International journal of molecular sciences.

[9]  J. Weisel,et al.  The distinctive structure and composition of arterial and venous thrombi and pulmonary emboli , 2020, Scientific Reports.

[10]  Amos A Cao,et al.  Collateral vein dynamics in mouse models of venous thrombosis: Pathways consistent with humans. , 2019, Thrombosis research.

[11]  Alberto Smith,et al.  Choosing a Mouse Model of Venous Thrombosis. , 2019, Arteriosclerosis, thrombosis, and vascular biology.

[12]  J. Weisel,et al.  Neutrophil α-defensins promote thrombosis in vivo by altering fibrin formation, structure, and stability. , 2019, Blood.

[13]  N. Leeper,et al.  Thrombotic Regulation From the Endothelial Cell Perspectives. , 2018, Arteriosclerosis, thrombosis, and vascular biology.

[14]  A. Tsung,et al.  Deep vein thrombosis in mice is regulated by platelet HMGB1 through release of neutrophil-extracellular traps and DNA , 2018, Scientific Reports.

[15]  A. Wolberg,et al.  Factor XIII in plasma, but not in platelets, mediates red blood cell retention in clots and venous thrombus size in mice. , 2018, Blood advances.

[16]  C. Maas,et al.  Antihistone Properties of C1 Esterase Inhibitor Protect against Lung Injury , 2017, American journal of respiratory and critical care medicine.

[17]  A. Walch,et al.  Disulfide HMGB1 derived from platelets coordinates venous thrombosis in mice. , 2016, Blood.

[18]  Simon C Watkins,et al.  Platelet-derived HMGB1 is a critical mediator of thrombosis. , 2015, The Journal of clinical investigation.

[19]  K. Inaba,et al.  The origin of fatal pulmonary emboli: a postmortem analysis of 500 deaths from pulmonary embolism in trauma, surgical, and medical patients. , 2015, American journal of surgery.

[20]  J. Marchesini,et al.  Factor XIII-A dynamics in acute myocardial infarction: a novel prognostic biomarker? , 2015, Thrombosis and Haemostasis.

[21]  W. Lam,et al.  Factor XIII activity mediates red blood cell retention in venous thrombi. , 2014, Journal of Clinical Investigation.

[22]  P. Libby,et al.  Neutrophil extracellular traps form predominantly during the organizing stage of human venous thromboembolism development , 2014, Journal of thrombosis and haemostasis : JTH.

[23]  J. Regal,et al.  Neutrophil Depletion Attenuates Placental Ischemia-Induced Hypertension in the Rat , 2013, PloS one.

[24]  N. Zhang,et al.  Circulating histones are mediators of trauma-associated lung injury. , 2013, American journal of respiratory and critical care medicine.

[25]  Kevin W Eliceiri,et al.  NIH Image to ImageJ: 25 years of image analysis , 2012, Nature Methods.

[26]  É. Katona,et al.  Factor XIII and inflammatory cells. , 2012, Thrombosis research.

[27]  A. Walch,et al.  Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo , 2012, The Journal of experimental medicine.

[28]  B. Lämmle,et al.  von Willebrand factor-mediated platelet adhesion is critical for deep vein thrombosis in mouse models. , 2011, Blood.

[29]  Jun Xu,et al.  Extracellular histones are major mediators of death in sepsis , 2009, Nature Medicine.

[30]  Heather A. Mitchell,et al.  Activated platelets induce Weibel-Palade-body secretion and leukocyte rolling in vivo: role of P-selectin. , 2005, Blood.

[31]  D. Loskutoff,et al.  Inhibition of Endogenous Leptin Protects Mice From Arterial and Venous Thrombosis , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[32]  S. Tognazzo,et al.  Factor XIII Contrasts the Effects of Metalloproteinases in Human Dermal Fibroblast Cultured Cells , 2004, Vascular and endovascular surgery.

[33]  T. Wakefield,et al.  Neutropenia impairs venous thrombosis resolution in the rat. , 2003, Journal of vascular surgery.

[34]  Michael Bustin,et al.  Inflammation-promoting activity of HMGB1 on human microvascular endothelial cells. , 2003, Blood.

[35]  G. Leftheriotis,et al.  Development of an experimental model of pre-thrombosis in rats based on Wessler's principle using a calibrated venous stasis , 2003, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[36]  S. Coughlin,et al.  Protection against thrombosis in mice lacking PAR3. , 2002, Blood.

[37]  S. Diamond,et al.  Neutrophil Enhancement of Fibrin Deposition Under Flow Through Platelet-Dependent and -Independent Mechanisms , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[38]  B. Bennett,et al.  Polymorphonuclear leucocytes mediate endogenous thrombus lysis via a u‐PA‐dependent mechanism , 2001, British journal of haematology.

[39]  Xiaoxing Luo,et al.  Cinnamaldehyde reduction of platelet aggregation and thrombosis in rodents. , 2007, Thrombosis research.